Dr. Daniel Joseph Ballow, MD

Dr. Ballow practices at Piedmont Newnan Hospital Ambulatory Surgery Center in Newnan, Georgia.

Dr. Ballow's NPI, 1811280373, was assigned on May 17, 2011. Dr. Ballow graduated from Texas Tech University Health Sciences Center at Lubbock in 2011. Dr. Ballow's Florida license number on file is ME125306.

Dr. Ballow's primary practice is Piedmont Newnan Hospital Ambulatory Surgery Center, at 775 Poplar Road, Suite Ll 10, Newnan, GA 30265. The practice phone is (770) 400-2111.

Dr. Ballow's primary practice is Piedmont Newnan Hospital Ambulatory Surgery Center in Newnan, Georgia. Dr. Ballow is also affiliated with Piedmont Newnan Hospital. The medical group on file is The Southeast Permanente Medical Group. Dmand AI also links Dr. Ballow to 3 more hospitals, 4 group practices and clinics, 4 medical groups and 1 breast imaging center, each named with a free account. Dr. Ballow's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ballow practices, 10 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ballow's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ballow is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ballow's licenses on file in 4 states: Florida, Georgia, Texas and West Virginia.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer, urinary endoscopy and UTI among the conditions Dr. Ballow treats.

CMS data shows 492 Medicare services from Dr. Ballow across 11 procedure codes in 2024, for 212 Medicare patients. Medicare paid $29,633 for them.

CMS counts 212 Medicare patients who saw Dr. Ballow in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ballow's median patient age at 68, with 18% women.

In 2024, Dr. Ballow wrote 522 Medicare Part D claims for 200 patients. 87% of them were for generic drugs. CMS names the drug for 360 of them, across 10 drugs with 11 or more claims each, at $33,007 in total drug cost. In 2023, CMS named 132 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ballow for performance year 2024, reported through an alternative payment model (APM). Dr. Ballow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Ballow, published from 2006 to 2017. The most frequent topics are Animals, Newborn, Ovary and Transcription Factors. Dr. Ballow's most frequent co-authors are Aleksandar Rajkovic, MD, Eduardo Javier Eyzaguirre, MD and Daniel Z. Farishta.

CMS Open Payments shows 136 general payments to Dr. Ballow from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $1,979.

Dr. Ballow graduated from Texas Tech University Health Sciences Center at Lubbock in 2011.

Dr. Ballow is in network with 19 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.